Immunocore Holdings (IMCR) EBT Margin (2023 - 2026)
Immunocore Holdings' (IMCR) quarterly EBT Margin came in at 12.44% in Q1 2026, up 596.0% year-on-year from 1.79% in Q1 2025, and up 182.3% quarter-over-quarter from 15.12% in Q4 2025.
Immunocore Holdings (IMCR) EBT Margin (2023 - 2026) Analysis & Trends
Immunocore Holdings has disclosed EBT Margin across 4 years of filings, most recently posting 12.44% for Q1 2026.
- EBT Margin for Q1 2026 came in at 12.44%, up 596.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.89% (up 394.0% YoY), and the FY2025 annual result was 4.77%, up 1229.0% from the prior year.
- EBT Margin came in at 12.44% for Q1 2026 at Immunocore Holdings, up from 15.12% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 12.44% in Q1 2026 to a low of 36.55% in Q4 2023.
- The 4-year median for EBT Margin is 13.44% (2024), against an average of 13.38%.
- Peak annual rise in EBT Margin reached 4063 bps in 2025, while the deepest fall reached 730 bps in 2025.
- Immunocore Holdings' EBT Margin stood at 36.55% in 2023, then increased by 19 bps to 29.53% in 2024, then surged by 49 bps to 15.12% in 2025, then surged by 182 bps to 12.44% in 2026.
- The last three EBT Margin figures came in at 12.44% (Q1 2026), 15.12% (Q4 2025), and 0.29% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | 12.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.44% |
| Dec 31, 2025 | -15.12% |
| Sep 30, 2025 | 0.29% |
| Jun 30, 2025 | -9.90% |
| Mar 31, 2025 | 6.48% |
| Dec 31, 2024 | -29.53% |
| Sep 30, 2024 | 7.59% |
| Jun 30, 2024 | -13.44% |
| Mar 31, 2024 | -34.15% |
| Dec 31, 2023 | -36.55% |
| Sep 30, 2023 | 1.13% |
| Jun 30, 2023 | -28.15% |
| Mar 31, 2023 | -35.05% |